Individualized Treatment-Adjusted Risk Stratification in Newly Diagnosed Multiple Myeloma

被引：3

作者：

Maura, Francesco ^{[1
]}

Rajanna, Arjun Raj ^{[1
]}

Derkach, Andriy ^{[2
]}

Ziccheddu, Bachisio ^{[3
]}

Weinhold, Niels ^{[4
]}

Maclachlan, Kylee H. ^{[5
]}

Diamond, Benjamin ^{[1
]}

Davies, Faith E. ^{[6
]}

Boyle, Eileen ^{[6
]}

Walker, Brian A. ^{[7
]}

Poos, Alexandra M. ^{[4
]}

Hultcrantz, Malin ^{[5
]}

Silva, Ariosto Siqueira ^{[8
]}

Hampton, Oliver ^{[9
]}

Teer, Jamie ^{[8
]}

Bolli, Niccolo ^{[10
,11
]}

Jackson, Graham ^{[12
]}

Kaiser, Martin F. ^{[13
]}

Pawlyn, Charlotte ^{[13
]}

Cook, Gordon ^{[14
]}

Verducci, Dennis ^{[1
]}

Kazandjian, Dickran ^{[1
]}

van Rhee, Frits ^{[15
]}

Usmani, Saad ^{[16
]}

Shain, Ken H. ^{[8
]}

Raab, Marc S. ^{[4
]}

Morgan, Gareth J. ^{[6
]}

Landgren, Ola ^{[3
]}

机构：

[1] Univ Miami, Sylvester Comprehens Canc Ctr, Myeloma Div, Miami, FL USA

[2] Mem Sloan Kettering Canc Ctr, Dept Biostat & Epidemiol, 1275 York Ave, New York, NY 10021 USA

[3] Univ Miami, Sylvester Comprehens Canc Ctr, Myeloma Serv, Miami, FL USA

[4] Univ Hosp Heidelberg, Dept Internal Med 5, Multiple Myeloma Res Grp, Heidelberg, Germany

[5] Mem Sloan Kettering Canc Ctr, Dept Med, Myeloma Serv, 1275 York Ave, New York, NY 10021 USA

[6] NYU Langone, Perlmutter Canc Ctr, New York, NY USA

[7] Indiana Univ, Melvin & Bren Simon Comprehens Canc Ctr, Div Hematol Oncol, Indianapolis, IN 46204 USA

[8] H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, Tampa, FL USA

[9] M2GEN, Tampa, FL USA

[10] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Hematol Unit, Milan, Italy

[11] Univ Milan, Milan, Italy

[12] Dept Haematol, NCCC Freeman Rd Hosp, Newcastle Upon Tyne, Tyne & Wear, England

[13] Inst Canc Res, London, England

[14] Leeds Teaching Hosp NHS Trust, Leeds, W Yorkshire, England

[15] Univ Arkansas Med Sci, Myeloma Ctr, Little Rock, AR 72205 USA

[16] Mem Sloan Kettering Canc Ctr, Myeloma Serv, New York, NY USA

来源：

BLOOD | 2022年 / 140卷

关键词：

D O I：

10.1182/blood-2022-160215

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1561 / 1563

页数：3

共 50 条

[41] Treatment of newly diagnosed multiple myeloma: advances in current therapy
Shaji Kumar
Medical Oncology, 2010, 27 : 14 - 24
[42] Carfilzomib with immunomodulatory drugs for the treatment of newly diagnosed multiple myeloma
Landgren, Ola
Sonneveld, Pieter
Jakubowiak, Andrzej
Mohty, Mohamad
Iskander, Karim S.
Mezzi, Khalid
Siegel, David S.
LEUKEMIA, 2019, 33 (09) : 2127 - 2143
[43] Management of Newly Diagnosed Symptomatic Multiple Myeloma: Updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Guidelines
Kumar, Shaji K.
Mikhael, Joseph R.
Buadi, Francis K.
Dingli, David
Dispenzieri, Angela
Fonseca, Rafael
Gertz, Morie A.
Greipp, Philip R.
Hayman, Suzanne R.
Kyle, Robert A.
Lacy, Martha Q.
Lust, John A.
Reeder, Craig B.
Roy, Vivek
Russell, Stephen J.
Short, Kristen E. Detweiler
Stewart, A. Keith
Witzig, Thomas E.
Zeldenrust, Steven R.
Dalton, Robert J.
Rajkumar, S. Vincent
Bergsagel, P. Leif
MAYO CLINIC PROCEEDINGS, 2009, 84 (12) : 1095 - 1110
[44] Development and validation of an individualized and weighted Myeloma Prognostic Score System (MPSS) in patients with newly diagnosed multiple myeloma
Mao, Xuehan
Yan, Wenqiang
Mery, David
Liu, Jiahui
Fan, Huishou
Xu, Jingyu
Xu, Yan
Sui, Weiwei
Deng, Shuhui
Zou, Dehui
Du, Chenxing
Yi, Shuhua
van Rhee, Frits
Barlogie, Bart
Shaughnessy Jr, John D.
Anderson, Kenneth C.
Zhan, Fenghuang
Qiu, Lugui
An, Gang
AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (04) : 523 - 533
[45] Development and validation of an individualized and weighted myeloma prognostic score system (MPSS) in patients with newly diagnosed multiple myeloma
Yan, Wenqiang
Mao, Xuehan
David, Mery
Xu, Yan
Zou, Dehui
Shaughnessy, John
Anderson, Kenneth
Zhan, Fenghuang
Qiu, Lugui
An, Gang
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S130 - S131
[46] Newly diagnosed multiple myeloma.
Weber D.M.
Current Treatment Options in Oncology, 2002, 3 (3) : 235 - 245
[47] Bortezomib in newly diagnosed multiple myeloma
James R. Berenson
Nature Reviews Clinical Oncology, 2009, 6 : 255 - 256
[48] Bortezomib in newly diagnosed multiple myeloma
Berenson, James R.
NATURE REVIEWS CLINICAL ONCOLOGY, 2009, 6 (05) : 255 - 256
[49] Isatuximab, Carfilzomib, Lenalidomide, and Dexamethasone for the Treatment of High-Risk Newly Diagnosed Multiple Myeloma
Leypoldt, Lisa B.
Tichy, Diana
Besemer, Britta
Haenel, Mathias
Raab, Marc S.
Mann, Christoph
Munder, Markus
Reinhardt, Hans Christian
Nogai, Axel
Goerner, Martin
Ko, Yon-Dschun
de Wit, Maike
Salwender, Hans
Scheid, Christof
Graeven, Ullrich
Peceny, Rudolf
Staib, Peter
Dieing, Annette
Einsele, Hermann
Jauch, Anna
Hundemer, Michael
Zago, Manola
Pozek, Ema
Benner, Axel
Bokemeyer, Carsten
Goldschmidt, Hartmut
Weisel, Katja C.
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (01) : 26 - +
[50] Multiple myeloma in Korea: risk stratification and initial treatment
Yoon, Sung-Soo
BLOOD RESEARCH, 2018, 53 (03) : 183 - 184

← 1 2 3 4 5 →